# Extendicare

## PROCEDURE

**MANUAL:** Infection Prevention and Control
**INDEX:** IPC6-P10.02
**SECTION:** Multi-Drug-Resistant Organisms (MDROs)
**DESCRIPTION:** Methicillin Resistant Staphylococcus Aureus (MRSA)
**APPROVED BY:** Chief Medical Officer
**EFFECTIVE DATE:** February 18, 2025
**REVIEWED DATE:** February 11, 2025
**MODIFIED DATE:** May 30, 2025

----

## POLICY

### Multi-Drug-Resistant Organisms (MDROs)

## PROCEDURE

### Screening
- The MDRO Screening Tool will be completed within 24 hours of admission or readmission from hospital where stay was greater than 12 hours.
- If warranted by the MDRO Screening Tool or per health authority requirements, collect surveillance specimens for MRSA.
- Screening includes:
- Anterior nares
- Perianal, perineal or groin area (perianal preferred)
- Open wounds, skin lesions, incisions, ulcers and exit site of indwelling devices, if present
- Laboratory results will be recorded in the health care record and HealthConnex (if applicable).

### Management
- Decolonization is not effective and not recommended.
- For a MRSA infection, implement Contact Precautions and as per health authority guidelines.
- For a MRSA colonization, implement Contact Precautions for direct care.
- Follow VRE & MRSA Screening Surveillance Algorithm for surveillance testing.

### Retirement Specific:
- If MRSA is identified, it will be noted on the plan of care. Appropriate precautions will remain in place until it is cleared, or the Resident moves out.

### Alberta and Manitoba Specific:
- Admission testing for MRSA is not recommended.
- Maintain routine practices, implement additional precautions if required based on a risk assessment.

## EDUCATION
Helplng people
Iva better

----

> This document is uncontrolled when printed.
> Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025
> Page 1 of 2

# PROCEDURE

## SECTION: Multi-Drug-Resistant Organisms (MDROs)

### DESCRIPTION: Methicillin Resistant Staphylococcus Aureus (MRSA)

#### INDEX: IPC6-P10.02

1. **IPC6-P10-E1** - MDRO Guide
2. **IPC6-P10-E3** - Methicillin Resistant Staphylococcus aureus (MRSA) Fact Sheet

### TOOLS

1. **IPC6-P10-T1** – MDRO Screening Tool
2. **IPC6-P10-T5** - Testing Program for Multi-Drug-Resistant-Organism (MDRO) Algorithm

----

Helping people live better

This document is uncontrolled when printed. Extendicare (Canada) Inc. will provide, on request, information in an accessible format or with communication supports to people with disabilities, in a manner that takes into account their disability. Confidential and Proprietary Information of Extendicare (Canada) Inc. © 2025

----

Page 2 of 2